Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Oncternal Therapeutics In...

    NASDAQ: ONCT · Real-Time Price · USD
    0.53
    -0.16 (-23.63%)
    At close: Dec 02, 2024, 10:00 PM

    Oncternal Therapeutics Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 785K 1.49M 4.32M
    Cost of Revenue
    		 29.75M 179K 169K
    Gross Profit
    		 -28.97M 1.31M 4.15M
    Operating Income
    		 -41.71M -44.95M -31.37M
    Interest Income
    		 2.23M 777K 33K
    Pretax Income
    		 -39.48M -44.17M -31.33M
    Net Income
    		 -39.48M -43.39M -31.3M
    Selling & General & Admin
    		 12.75M 13.46M 11.6M
    Research & Development
    		 29.75M 32.98M 24.09M
    Other Expenses
    		 -29.75M -1.49M -4.32M
    Operating Expenses
    		 12.75M 44.95M 31.37M
    Interest Expense
    		 n/a n/a n/a
    Selling & Marketing Expenses
    		 200K n/a n/a
    Cost & Expenses
    		 42.5M 44.95M 31.37M
    Income Tax Expense
    		 n/a -777K -33K
    Shares Outstanding (Basic)
    		 2.94M 2.63M 16.11M
    Shares Outstanding (Diluted)
    		 2.94M 2.63M 16.11M
    EPS (Basic)
    		 -13.43 -16.5 -1.94
    EPS (Diluted)
    		 -13.43 -16.5 -1.94
    EBITDA
    		 2.23M -44.95M -31.37M
    EBIT
    		 -39.48M -44.17M -31.33M
    Depreciation & Amortization
    		 41.71M 179K 169K

    Add to Watchlist